Effects of a DPP4 inhibitor on cisplatin-induced acute kidney injury: study protocol for a randomized controlled trial

BACKGROUND: Cisplatin is a potent chemotherapeutic agent, but its nephrotoxicity, which results in acute kidney injury (AKI), often limits its clinical application. Although many studies have attempted to target the mechanism responsible for its nephrotoxicity, no such method has been demonstrated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, Seon Ha, Kim, Se Hyun, Kim, Jin Won, Kim, Yu Jung, Lee, Keun-Wook, Na, Ki Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449575/
https://www.ncbi.nlm.nih.gov/pubmed/26021829
http://dx.doi.org/10.1186/s13063-015-0772-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449575/
https://www.ncbi.nlm.nih.gov/pubmed/26021829
http://dx.doi.org/10.1186/s13063-015-0772-4

Ejemplares similares